Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency
A trial evaluating niraparib versus bevacizumab as maintenance therapy in patients with de novo ovarian cancer without homologous recombinat…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: The DIALOGUE Study: Swiss-Korean Billateral Collaboration [NA]
The DIALOGUE Study, a Swiss-Korean bilateral clinical trial sponsored by the University of Basel, is currently recruiting to study hereditar…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS other · 2025-02-13Clinical Trial Update: Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors [EARLY_Phase 1]
Early-phase Phase 1 trial evaluating allogeneic B7H3 CAR-γδT cell therapy for advanced solid tumors and ovarian cancer; not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Prehabilitation for Ovarian Cancer Patients [NA]
A clinical trial investigating prehabilitation for ovarian cancer patients is currently recruiting. The study, sponsored by the Nova Scotia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers [NA]
This entry reports on the development of a clinical and biological database for ovarian, fallopian tube, and peritoneal cancers, sponsored b…
-
CLINICAL_TRIALS withdrawal · 2025-02-12Clinical Trial Update: Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency [Phase 2]
Phase 2 trial of upfront maintenance olaparib in advanced BRCA wild-type ovarian cancer with homologous recombination deficiency has been wi…
-
CLINICAL_TRIALS withdrawal · 2025-02-12Clinical Trial Update: Avastin Plus Chemotherapy vs. Avastin Plus Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Ovarian Cancer [Phase 3]
A Phase 3 trial comparing Avastin plus chemotherapy with a cancer stem cell test–guided approach in recurrent ovarian cancer has been withdr…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: Intensive Intraperitoneal Therapy in Advanced Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating intensive intraperitoneal chemotherapy for advanced ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America
This Clinical Trial Update reports that niraparib is being evaluated under an Expanded Access Program for ovarian cancer in Latin America, s…
-
CLINICAL_TRIALS trial_result · 2025-02-11Clinical Trial Update: ATALANTE: Atezolizumab vs Placebo Phase III Study in Late Relapse Ovarian Cancer Treated With Chemotherapy+Bevacizumab [Phase 3]
A Phase III trial (ATALANTE) evaluated atezolizumab versus placebo in late-relapse ovarian cancer patients treated with chemotherapy plus be…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/II trial update for VB15010 tablets in advanced solid tumors; the study is currently recruiting across multiple cancer types.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer [Phase 3]
Phase 3 clinical trial comparing nab-paclitaxel with solvent-based taxanes as first-line therapy for advanced ovarian cancer is currently re…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: Phase 1 Dose Escalation of ArtemiCoffee [Phase 1]
Phase 1 dose-escalation trial of ArtemiCoffee in ovarian cancer has completed; this document provides an update on the study's status.
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of surgery with maintenance targeted therapy for advanced ovarian cancer is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-02-10Clinical Trial Update: A Study of SGN-ALPV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-ALPV in advanced solid tumors has been terminated; the trial evaluated multiple cancers including ovarian, end…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: A Study of SGN-STNV in Advanced Solid Tumors [Phase 1]
Seagen's Phase 1 study of SGN-STNV in advanced solid tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies [Phase 2]
This clinical trial update reports on a Phase 2 study of XmAb20717 (Vudalimab) in selected advanced gynecologic and genitourinary cancers, w…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. [Phase 1, Phase 2]
Clinical trial update indicating an early-phase study of XNW27011 for multiple advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study [NA]
A pilot study evaluating an ACT-based nursing intervention to reduce psychological distress in ovarian cancer patients. The trial status is …
-
CLINICAL_TRIALS research · 2025-02-05Clinical Trial Update: Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer [Phase 1]
Phase 1 clinical trial of a microdevice for ovarian, fallopian tube, and peritoneal cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-04Clinical Trial Update: A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
This clinical trial update indicates that Cleo Diagnostics Ltd is recruiting participants for a study evaluating a diagnostic test to assess…
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
A clinical trial network in Ontario (MOHCCN-O) is currently recruiting across multiple cancer indications, including breast, colorectal, pan…
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) [NA]
Completed feasibility testing of the Informed Symptom Management System (PRISMS) for collecting patient-reported outcomes in cancer patients…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of SL-172154 (SIRPα-Fc-CD40L) in ovarian, fallopian tube, and primary peritoneal cancers has completed enrollment and posted r…